Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant
This study investigated how pH and the presence of urea affect the survival and growth of Helicobacter pylori and whether these factors affect susceptibility to antibiotics in vitro. The viability of a wild-type strain and a urease-deficient mutant of H. pylori was studied after incubation for 1 h in buffers at different pH values at 37°C under microaerophilic conditions. Viable counts were not affected at pH 5 and pH 7. In buffer at pH 3, there were no viable organisms, but urea (6.25 mm) protected the wild-type strain, which survived well. At pH 9, urea further reduced the viability of H. pylori and flurofamide almost abolished the effect of urea on the wild-type strain. Neither urea nor flurofamide affected the viability of the urease-deficient mutant under the same conditions. Growth was also pH dependent and was enhanced in shake-cultures. At pH 5, urea supported growth of the wild-type strain, but at pH 7 a toxic effect on the bacteria was observed. Growth of H. pylori at pH 5.9 was poor, and susceptibility to amoxycillin, erythromycin and clarithromycin was markedly less than at pH 7.2 and 7.9. The bactericidal activities of metronidazole and tetracycline were similar at the different pH values studied. At neutral pH the killing rates of amoxycillin and clarithromycin were growth rate dependent. Susceptibility to metronidazole was enhanced in stationary cultures. The interaction obtained between the proton pump inhibitor, omeprazole, and amoxycillin at pH 7 was of additive type. These results suggest that pH and growth conditions may be important in the antibacterial efficacy of different antibiotics in vivo and also provide a possible explanation for the potentiating effect of omeprazole with antibiotics in the treatment of H. pylori infections.
GrahamD. Y.,
MalatyH. M.,
EvansD. G.,
EvansD. J.,
KleinP. D.,
AdamE. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology1991; 100:1495–1501
MarshallB. J.,
BarrettJ. L.,
PrakashC.,
McCallumR. W.,
GuerrantR. L. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology1990; 99:697–702
GoodwinC. S.,
CollinM. D.,
BlincowE. The absence of thermoplasmaquinones in Campylobacter pyloridis, and its temperature and pH growth range. Microbios Letters1986; 32:137–140
GreigM. A.,
NeithercutW. D.,
HossackM.,
McCollK. E. L. Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium. J Clin Pathol1991; 44:157–159
EatonK. A.,
BrooksC. L.,
MorganD. R.,
KrakowkaS. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun1991; 59:2470–2475
FerreroR. L.,
LeeA. The importance of urease in acid protection for the gastric-colonising bacteria, Helicobacter pylori and Helicobacter felis sp. nov. Microb Ecol Health Dis1991; 4:121–134
FlemströmG.,
GamerA. Gastroduodenal HCO−3 transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol1982; 242:G183–193
GlupczynskiY.In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment of microbiologists’ obsession?. Zentralbl Bakteriol1993; 280:227–238
GlupczynskiY.,
BuretteA.,
LabbeM.,
DeprezC.,
De ReuckM.,
DeltenreM.Campylobacterpylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol1988; 83:365–372
HirschlA. M.,
HentschelE.,
SchiitzeK. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol1988; 23: Suppl 14276–81
RauwsE. A.,
LangenbergW.,
HouthoffH. J.,
ZanenH. C.,
TytgatG. N. J.Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology1988; 94:33–40
ChibaN.,
RademakerJ. W.,
RaoB. V.,
HuntR. H. Eradication of Helicobacterpyloripylori-meta-analysis to determine optimal therapy. Gut1991; 32:A1220–A1221
TytgatG. N. J.,
AxonA. T. R.,
DixonM. F.,
GrahamD. Y.,
LeeA.,
MarshallB. J. World Congresses of Gastroenterology. Working Party Reports 36–45 Melbourne, Australia: Blackwell Scientific Publications;
PavicicM. J.,
NamavarF.,
VerboomT.,
van WinkelhoffA. J.,
De GraaffJ.In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations. Antimicrob Agents Chemother1993; 37:1184–1186
van CaekenbergheD. L.,
BreyssensJ.In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Antimicrob Agents Chemother1987; 31:1429–1430
GraysonM. L.,
EliopoulosG. M.,
FerraroM. J.,
MoelleringR. C. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis1989; 8:888–889
MalanoskiG. J.,
EliopoulosG. M.,
FerraroM. J.,
MoelleringR. C. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis1993; 12:131–133
McNultyC. A. M. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In
RathboneB. J.,
HeatleyR. V.
(eds) Campylobacter pylori and gastroduodenal disease Oxford: Blackwell Scientific Publications; 1989209–216
UngeP.,
GadA.,
GnarpeH.,
OlssonJ. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol1989; 24: Suppl 16749–54
BazzoliF.,
ZagariR. M.,
FossiP. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol1994; 6:773–777
MégraudF.,
TrimouletP.,
LamouliatteH.,
BoyanovaL. Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob Agents Chemother1991; 35:869–872
FerreroR. L.,
CussacV.,
CourcouxP.,
LabigneA. Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange. J Bacteriol1992; 174:4212–4217
KrogstadD. J.,
MoelleringR. C. Antimicrobial combinations. In
LorianV.
(ed) Antibiotics in laboratory medicine 2nd edn Baltimore: The Williams and Wilkins Co; 1986537–595
NeithercutW. D.,
GreigM. A.,
HossackM.,
McCollK. E. L. Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia. J Clin Pathol1991; 44:380–384
CoudronP. E.,
KirbyD. F. Comparison of rapid urease test, staining techniques, and growth on different solid media for detection of Campylobacter pylori. J Clin Microbiol1989; 27:1527–1530
ShahamatM.,
MaiU. E. H.,
Paszko-KolvaC.,
YamamotoH.,
ColwellR. R. Evalution of liquid media for growth of Helicobacter pylori. J Clin Microbiol1991; 29:2835–2837
LoganR. P. H.,
GummettP. A.,
HegartyB. T.,
WalkerM. M.,
BaronJ. H.,
MisiewiczJ. J. Clarithromycin and omeprazole for Helicobacter pylori. Lancet1992; 340:239
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant